Ulrich Wandschneider is a businessperson who has been at the helm of 12 different companies. Presently, Dr. Wandschneider occupies the position of Chairman-Supervisory Board for Broermann Holding GmbH and Operating Partner at Trilantic Capital Partners LLP.

He is also on the board of Vanguard AG, BioNTech SE, Hanns Martin Schleyer-Stiftung and Marienhaus gGmbH.

Dr. Wandschneider previously held the position of Chairman-Supervisory Board for MediClin AG Managing Director at MediClin Müritz-Klinikum GmbH & Co. KG, Managing Director at MediClin Geschäftsführungs GmbH, Managing Director at MediClin Medizinisches Versorgungszentrum GmbH, Managing Director at MVZ MediClin Bonn GmbH, Managing Director at Yvonne Mobilien Leasing GmbH and Managing Director at MVZ-Müritz GmbH (which are all subsidiaries of MediClin AG), Managing Director at beebusy capital GmbH, Vice President at Bundesverband Deutscher Privatkliniken eV, Chairman-Supervisory Board of Asklepios Kliniken Verwaltungs GmbH, Chairman-Supervisory Board of Asklepios Kliniken GmbH & Co. KGaA, Managing Director at Kraichgau-Klinik AG, Principal at Arthur Andersen & Co. GmbH and Partner at Deloitte Consulting GmbH.

Ulrich Wandschneider received an undergraduate degree from the University of Hamburg and an undergraduate degree from the University of Zurich.